| Diagnosis | N | % | N | % | N | % | N | % | N | % |
|---|---|---|---|---|---|---|---|---|---|---|
| Endocervical adenocarcinoma | 13 | 0.2% | 10 | 0.7% | 7 | 0.5% | 0 | 0.0% | 30 | 0.3% |
| Squamous cell carcinoma | 49 | 0.8% | 24 | 1.6% | 11 | 0.8% | 0 | 0.0% | 84 | 1.0% |
| Other cervical carcinoma | 2 | 0.0% | 0 | 0.0% | 2 | 0.1% | 0 | 0.0% | 4 | 0.0% |
| AIS | 21 | 0.4% | 27 | 1.8% | 8 | 0.6% | 0 | 0.0% | 56 | 0.6% |
| HSIL/CIN3 | 563 | 9.6% | 695 | 46.9% | 33 | 2.4% | 0 | 0.0% | 1,291 | 14.8% |
| HSIL/CIN2 | 245 | 4.2% | 213 | 14.4% | 10 | 0.7% | 0 | 0.0% | 468 | 5.4% |
| LSIL | 1,174 | 20.0% | 246 | 16.6% | 81 | 5.9% | 0 | 0.0% | 1,501 | 17.2% |
| Benign changes | 2,852 | 48.6% | 195 | 13.2% | 647 | 47.1% | 2 | 100.0% | 3,696 | 42.4% |
| No pathological findings | 675 | 11.5% | 58 | 3.9% | 576 | 41.9% | 0 | 0.0% | 1,309 | 15.0% |
| Evaluation not possible | 269 | 4.6% | 14 | 0.9% | 0 | 0.0% | 0 | 0.0% | 283 | 3.2% |
| Data not available | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
| Total | 5,863 | 100.0% | 1,482 | 100.0% | 1,375 | 100.0% | 2 | 100.0% | 8,722 | 100.0% |